8.30 - 9.00am Registration open

9.00 - 9.10am

Welcome and Official Opening

Glenn Cross, Chief Executive Officer, AusBiotech Ltd

9.10 - 10.15am

Company Spotlight Presentations

Dr Bill Ketelbey, Chief Executive Officer & Managing Director, Actinogen Medical Ltd
Daniel Kelly, Chief Executive Officer & Managing Director, OncoSil Medical Ltd
Dr Brad Walsh, Chief Executive Officer, Minomic International Ltd
Kathy Harrison, Chief Executive Officer, Dimerix Ltd
Sam Cobb, Chief Excutive Officer, AdAlta Pty Ltd
Dr James Garner, Chief Executive Officer, Novogen
Dr Jeremy Chrisp, Chief Executive Officer, EpiAxis Therapeutics
Dr Paul MacLeman, Managing Director & Chief Executive Officer, IDT Australia
Tom Howitt, Chief Financial Officer, Global Kinetics

Spotlight presentations proudly supported by 

10.15 - 11.00am Morning tea and networking opportunity

11.00 - 12.30pm

Company Spotlight Presentations

Yacov Geva, President and Chief Executive Officer, G Medical
Steven Yatomi-Clarke, Chief Executive Officer and Managing Director, Prescient Therapeutics
Dr Peter Jenkins, Executive Director, Aus Bio Limited
David Russell,
Chief Operating Officer, Creso Pharma Ltd

Spotlight presentations proudly supported by 

12.30 - 1.30pm Lunch and networking opportunity

1.30 - 3.00pm Company Spotlight Presentations

3.00 - 3.30pm Afternoon tea and networking opportunity

3.30 - 4.55pm Company Spotlight Presentations

4.55 - 5.00pm

Close of Conference

Glenn Cross, Chief Executive Officer, AusBiotech Ltd

5.00 - 6.00pm

Australia Biotech Invest 2017 Networking Reception

Foyer, Sofitel Melbourne on Collins